Bafna Pharmaceuticals Ltd awarded with MSME-ZED certified Gold Certificate

Bafna Pharmaceuticals Limited has been awarded MSMEZED Gold Certificate by the Ministry of Micro, Small & Medium Enterprises, Government of India.

Strides Pharma Science successfully completes WHO PQ inspection at Puducherry facility

Strides Pharma Science Limited (Strides) has successfully completed the inspection carried out by the World Health Organization (WHO) at its Puducherry facility between 16-20 January 2023. The Puducherry facility caters to the U.S., Other Regulated Markets, and Institutional businesses and can produce finished dosage formulation products across multiple dosage formats.

IOL Chemicals and Pharmaceuticals receives EUGMP certification from Hungary authorities

The National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for IOL Chemicals and Pharmaceuticals Limited's products. Now following products are having EUGMP Certification:

1. IBUPROFEN

2. LAMOTRIGINE

3. METFORMIN HYDROCHLORIDE

4. FENOFIBRATE

5. CLOPIDOGREL HYDROGEN SULFATE

6. PANTOPRAZOLE SODIUM SESQUIHYDRATE

7. GABAPENTIN

8. LEVETIRACETAM

9. LOSARTAN POTASSIUM

10. PARACETAMOL

11. IBUPROFEN SODIUM DIHYDRATE

12. IBUPROFEN LYSINATE

With this certification, the company will have more penetration in European Market for its products.

Krsnaa Diagnostics commissions new Diagnostic Centers at Himachal Pradesh

Krsnaa Diagnostics Limited had earlier announced about winning of a Tender for providing Diagnostic / Laboratory Services in H.P. Govt. Health Institutions in entire State of Himachal Pradesh in the month of February, 2022 and operationalization of Pathology Labs and Collection Centers during September, 2022. The Company has now operationalized additional 14 Pathology Labs and 64 Collection Centers and thereby completed 100% of the Project Implementation as on the date.